Difference between revisions of "Quell relief"

From HCE Wiki - The Human Cognitive Enhancement Wiki
Jump to: navigation, search
(→‎Wearable kit with accessories: update)
(→‎Company & People: update)
Line 96: Line 96:
  
  
−
People in the lead of the company (the complete description is [http://www.neurometrix.com/about-neurometrix/management-team.html here]):
+
Directors of Neurometrix<ref>Neurometrix, Board of directors: http://www.neurometrix.com/about-neurometrix/board-of-directors.html</ref>:
  
−
Shai N. Gozani, M.D., Ph.D. - President, Chief Executive Officer and Director
+
Shai N. Gozani, M.D., Ph.D.
  
−
Thomas T. Higgins - Senior Vice President and Chief Financial Officer
+
Allen Hinkle, M.D.
  
−
Frank McGillin - Senior Vice President and General Manager, Consumer
+
David E. Goodman, M.D
 +
 
 +
Timothy R. Surgenor
 +
 
 +
Nancy E. Katz
 +
 
 +
David Van Avermaete
  
−
Michael J. MacDonald - Senior Vice President of Commercial Operations
 
  
−
Juan Kong, Ph.D. - Senior Vice President of Research and Intellectual Property
 
  
  

Revision as of 07:17, 10 November 2015

Quell wearable is device designated for treatment of chronic pain. It works on principle of transcutaneous electrical nerve stimulation, which causes release of endogenous opiates affecting pain relief.

QUELL RELIEF
Quell.jpg
Category Therapeutic wearables
Developer NeuroMetrix
Announced Oct 2015
Released Consumers: 2015
Price 249 USD
Weight 62 g
Dimensions 98 x 74 x 11 mm
Controls smartphone
Standalone[1]
https://www.quellrelief.com/product


Main characteristics

Wearable kit with accessories

The basic product you can buy, called Quell wearable pain relief - starter kit[2], includes one piece of Quell device, adjustable sports band, charger cable, and charger adapter, and two 2 electrodes (supplying one month).

User have to buy accessories in addition like travel bag, spare cables, charger adapter, sports band[3]. And also two electrodes, user has to buy regularly, and which are currently available in two kinds of packages: one package of two electrodes (company claims one month supply) for 29.95$, or three packages of two electrodes for 89.85$[4].

A) A therapy pod, B) An electrode array, C) A Band, D) An example of usage on upper calf, place of effect[5]

Purpose

Quell wearable is device designated for treatment of chronic pain, nerve deseases and disrupted sleep[6]. It works on principle of transcutaneous electrical nerve stimulation, which causes release of endogenous opiates affecting pain relief.

Company & People

Neurometrix is company directed on developing health-care wearable technology with main effort on sleep disorders, chronical pain, and nerve deseases treatment. The company, having a seat in Waltham Massachusetts, was founded in 1996 as a spinoff of the Harvard-MIT partition of Health Sciences and Technology.[7][8]

Currently Neurometrix offers four products in total[9]:

Quell™ - Wearable device for paliative purpose

SENSUS® - Therapy device available on prescription. It is based on TENS technology also for pain relief without any drug usage.

DPNCheck® - Nerve conduction test for evaluating systemic neuropathies such as diabetic peripheral neuropathy (DPN), its detection and monitoring.

ADVANCE™ System


Directors of Neurometrix[10]:

Shai N. Gozani, M.D., Ph.D.

Allen Hinkle, M.D.

David E. Goodman, M.D

Timothy R. Surgenor

Nancy E. Katz

David Van Avermaete



Neurometrix stated also contact persons for media, which is Laura Wagstaff[11], and Thomas T. Higgins as contact person for investor relations[12].

Important Dates

1965 - Melzack and Wall proposed first conceptual model for mechanism which could lead to pain relief

1970s - Developement of TENS (Transcutaneous electrical nerve stimulation)

Ethical Issues

Health Risks

Official statement about side effects is that there are none[1]. Usage is 100% drug free, with clearance by FDA (Food and Drug Administration) received in 2014.

Enhancement/Therapy/Treatment

Quell wearable device has primarily therapeutical function. It was developed on purpose to palliate chronical pain which basically has origin in these four diseases:

Public & Media Impact and Presentation

Advertising video found right on the Quell product website.

Public Policy

Quell received clearance from Food and Drug Administration, which is federal agency as part of Department of Health and Human Services. FDA is connected to the database on U.S. Government Publishing Office, Electronic Code of Federal Regulations (eCFR). This eCFR contains also of three chapters (I. Food and Drug Administration, Department of Healt and Human Services; II. Drug Enforcement Administration, Department of Justice; III. Office of National Drug Control Policy), where medical devices are sorted and classified according to specific properties, difficulties of usage, dangerousness, etc. It the chapter I, Quell description consists of a) identification and b) classification. Quell is kept under regulation number: 882.5890, and it is identified as "A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain"[13] . Further, it is classified with a "Class II (performance standards)"[14]. The latter category features most of medical devices (FDA stated 43%), including for example wheelchairs of pregnancy test kits[15].

Related Technologies, Project or Scientific Research

References

  1. ↑ Shows if the device is a standalone wearable computer or if it needs to be connected to a processing unit to function.
  2. ↑ Quell wearable pain relief, starter kit, online shop webpage: https://store.quellrelief.com/products/quell-wearable-pain-relief
  3. ↑ Quell, Accessories, Online shop webpage: https://store.quellrelief.com/collections/accessories
  4. ↑ Quell, Electrodes, Online shop webpage: https://store.quellrelief.com/collections/electrodes
  5. ↑ Shai N. Gozani, Science Behind Quell™ Wearable Pain Relief Technology for Treatment of Chronic Pain: https://www.quellrelief.com/files/science-behind-quell.pdf
  6. ↑ Neurometrix, Company overview: http://www.neurometrix.com/about-neurometrix/company-overview.html
  7. ↑ Neurometrix, Company overview: http://www.neurometrix.com/about-neurometrix/company-overview.html
  8. ↑ NeuroMetrix Launches Quell™ Wearable Pain Relief Technology: http://www.businesswire.com/news/home/20150615005489/en/
  9. ↑ Neurometrix, Company overview: http://www.neurometrix.com/about-neurometrix/company-overview.html
  10. ↑ Neurometrix, Board of directors: http://www.neurometrix.com/about-neurometrix/board-of-directors.html
  11. ↑ NeuroMetrix Launches Quell™ Wearable Pain Relief Technology: http://www.businesswire.com/news/home/20150615005489/en/
  12. ↑ NeuroMetrix Launches Quell™ Wearable Pain Relief Technology: http://www.businesswire.com/news/home/20150615005489/en/
  13. ↑ Code of Federal Regulations, Title 21, Volume 8, 21CFR882.5890 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRsearch.cfm?FR=882.5890
  14. ↑ Code of Federal Regulations, Title 21, Volume 8, 21CFR882.5890 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRsearch.cfm?FR=882.5890
  15. ↑ Medical device classification list on: http://www.fda.gov/MedicalDevices/ResourcesforYou/Consumers/ucm142523.htm
Retrieved from "http://hcenat.zcu.cz/wiki/index.php?title=Quell_relief&oldid=1281"